Microbiology & Infectious Diseases

A new clinical practice guideline for well-appearing febrile infants has led to a reduction in hospitalisations, antibiotic use, and invasive procedures.

Individuals who experience multiple COVID-19 infections are at greater risk of developing post-acute sequelae of COVID-19.

Research has identified microRNAs as potential biomarkers for predicting COVID-19-related mortality in patients with cancer.

Nasal microbiota transplantation could revolutionise the treatment of chronic rhinosinusitis and respiratory tract infections.

Aztreonam–avibactam is a promising treatment for complicated intra-abdominal infections and hospital-acquired or ventilator-associated pneumonia caused by Gram-negative bacteria.

Elevated uric acid levels in children with severe malaria are associated with significantly increased risks of death and long-term cognitive impairment.

A novel clinical decision support system, TBorNotTB, has been developed to assist clinicians in diagnosing pulmonary tuberculosis in low-prevalence settings.

Women are at a significantly higher risk of developing long COVID compared to men, especially between the ages of 40–55 years.